Certara Announces PK Submit


Applied Clinical Trials

Certara has announced the availability of PK Submit, a technology solution for automating the creation of PK Clinical Data Interchange Standards Consortium (CDISC ) domains during Non-Compartmental Analysis.

For more information on PK Submit, click here. 

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.